Filed: 2026-02-04 AccNo: 0001193125-26-037993 Size: 188 KB Source: S-1MEF – Eikon Therapeutics, Inc. (0001861123) (Filer)
S-1MEF – Hennessy Capital Investment Corp. VIII (0002099093) (Filer)
Filed: 2026-02-04 AccNo: 0001493152-26-005135 Size: 409 KB Source: S-1MEF – Hennessy Capital Investment Corp. VIII (0002099093) (Filer)
S-1/A – Iveda Solutions, Inc. (0001397183) (Filer)
Filed: 2026-02-04 AccNo: 0001493152-26-005133 Size: 11 MB Source: S-1/A – Iveda Solutions, Inc. (0001397183) (Filer)
S-1/A – 21Shares Sei ETF (0002061623) (Filer)
Filed: 2026-02-04 AccNo: 0001213900-26-012356 Size: 1 MB Source: S-1/A – 21Shares Sei ETF (0002061623) (Filer)
S-1 – Generate Biomedicines, Inc. (0002100782) (Filer)
Filed: 2026-02-04 AccNo: 0001193125-26-037799 Size: 61 MB Source: S-1 – Generate Biomedicines, Inc. (0002100782) (Filer)
S-4 – Community West Bancshares (0001127371) (Filer)
Filed: 2026-02-04 AccNo: 0001628280-26-005481 Size: 3 MB Source: S-4 – Community West Bancshares (0001127371) (Filer)
S-1/A – Global Industry Products, Corp. (0001466369) (Filer)
Filed: 2026-02-04 AccNo: 0001065949-26-000009 Size: 1 MB Source: S-1/A – Global Industry Products, Corp. (0001466369) (Filer)
primeGen US to Go Public in $1.5 Billion SPAC Deal – USA Herald
primeGen US to Go Public in $1.5 Billion SPAC Deal USA Herald Source: primeGen US to Go Public in .5 Billion SPAC Deal – USA Herald
Securities Class Action Filings 2025 Year in Review: Key Trends in Federal Filings
There were 16 filings in the AI trend category in 2025, with 12 filings occurring in 2025 H1 but only four filings occurring in 2025…
IPOs Rising: What SEC Data Says About Small and Pre-Public Companies
The SEC’s Office of the Advocate for Small Business Capital Formation (OASB) recently published a data-packed report that spotlights the ways smaller companies are getting…
Preclinical stem cell biotech PrimeGen takes SPAC route to Nasdaq – Fierce Biotech
Preclinical stem cell biotech PrimeGen takes SPAC route to Nasdaq Fierce Biotech Source: Preclinical stem cell biotech PrimeGen takes SPAC route to Nasdaq – Fierce Biotech
S-1/A – Climate Transition Special Opportunities SPAC I (0002085932) (Filer)
Filed: 2026-02-04 AccNo: 0001213900-26-011849 Size: 9 MB Source: S-1/A – Climate Transition Special Opportunities SPAC I (0002085932) (Filer)
Former Lottery.com SPAC Boss Admits Securities Fraud – Casino.org
Former Lottery.com SPAC Boss Admits Securities Fraud Casino.org Source: Former Lottery.com SPAC Boss Admits Securities Fraud – Casino.org
S-1/A – Clear Street Group Inc. (0001881567) (Filer)
Filed: 2026-02-04 AccNo: 0001193125-26-036739 Size: 10 MB Source: S-1/A – Clear Street Group Inc. (0001881567) (Filer)
Stem-Cell Drug Developer PrimeGen Inks $1.5B SPAC Merger – Law360
Stem-Cell Drug Developer PrimeGen Inks $1.5B SPAC Merger Law360 Source: Stem-Cell Drug Developer PrimeGen Inks .5B SPAC Merger – Law360
CLBR.U IPO News – SPAC Colombier Acquisition III prices $260 million US IPO, led by Omeed Malik – renaissancecapital.com
CLBR.U IPO News – SPAC Colombier Acquisition III prices $260 million US IPO, led by Omeed Malik renaissancecapital.com Source: CLBR.U IPO News – SPAC Colombier Acquisition…
S-1/A – Ernexa Therapeutics Inc. (0000748592) (Filer)
Filed: 2026-02-04 AccNo: 0001493152-26-004987 Size: 16 MB Source: S-1/A – Ernexa Therapeutics Inc. (0000748592) (Filer)
S-1MEF – Veradermics, Inc (0001827635) (Filer)
Filed: 2026-02-03 AccNo: 0001628280-26-005218 Size: 274 KB Source: S-1MEF – Veradermics, Inc (0001827635) (Filer)
Colombier Acquisition Corp. III Announces Pricing of $260 Million Initial Public Offering
New York, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) — Colombier Acquisition Corp. III (the “Company,” “Colombier III”) today announced the pricing of its initial public…
Aerospace Manufacturing Space Demands Surge With Federal Spending, Industry Innovation
Manufacturing in the U.S. pivoted in 2025, with a wave of expansions by aerospace and defense companies replacing clean energy projects that were paused or canceled…